<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Neurol</journal-id>
      <journal-title-group>
        <journal-title>Journal of Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0340-5354</issn>
      <issn pub-type="epub">1432-1459</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22349868</article-id>
      <article-id pub-id-type="pmc">3410027</article-id>
      <article-id pub-id-type="publisher-id">6443</article-id>
      <article-id pub-id-type="doi">10.1007/s00415-012-6443-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editors</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Increased rCBV in status epilepticus</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rath</surname>
            <given-names>J. J. G.</given-names>
          </name>
          <address>
            <phone>+31-10-7041415</phone>
            <fax>+31-10-7041031</fax>
            <email>j.rath@hagaziekenhuis.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smits</surname>
            <given-names>M.</given-names>
          </name>
          <address>
            <email>marion.smits@erasmusmc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ducray</surname>
            <given-names>F.</given-names>
          </name>
          <address>
            <email>francois.ducray@chu-lyon.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van den Bent</surname>
            <given-names>M. J.</given-names>
          </name>
          <address>
            <email>m.vandenbent@erasmusmc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Department of Neuro-oncology, H&#xF4;pital Neurologique, Lyon, France </aff>
        <aff id="Aff4"><label>4</label>Department of Neuro-oncology, Neurology, Daniel den Hoed Cancer Center, Erasmus Medical Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>2</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>14</day>
        <month>2</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2012</year>
      </pub-date>
      <volume>259</volume>
      <issue>8</issue>
      <fpage>1746</fpage>
      <lpage>1748</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>1</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>1</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2012</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2012</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Sirs,</p>
    <p>The estimated relative cerebral blood volume (rCBV) is a semiquantitative parameter that correlates with tissue vascularisation. High-grade gliomas are characterised by an increased macrovasculature and microvasculature, and therefore associated with an increased rCBV [<xref ref-type="bibr" rid="CR1">1</xref>]. In neuro-oncology, high rCBV is used to distinguish tumoral from non-tumoral increase in lesion size, e.g, pseudoprogression and radiation necrosis from real tumour progression. However, in high-grade glioma an increase in rCBV without tumour progression can also be observed in (non-convulsive) status epilepticus, as we will describe below.</p>
    <p>A 45-year-old woman was admitted to our hospital because of a complete paresis of the right arm and motor speech impairment. Thirteen years before she had been treated for an anaplastic oligodendroglioma of the left temporal lobe with surgery followed by radiotherapy (59.4&#xA0;Gy) and chemotherapy (6 cycles of procarbazine, CCNU, vincristin). Every 6&#xA0;months a magnetic resonance imaging (MRI) scan of the brain was performed showing a post-surgery cyst and local subtle enhancement, which remained stable over this period (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). Dynamic susceptibility contrast (DSC) perfusion-weighted MR imaging [T2*w gradient echo echo-planar imaging with repetition time of 2,000&#xA0;ms; 60 phases; contrast bolus injection after 10 phases at 5&#xA0;ml/s of 12&#xA0;ml of Gadovist<sup>&#xAE;</sup> 1.0 (Bayer Schering Pharma) followed by 20&#xA0;ml 0.9% NaCl; preload bolus of 3&#xA0;ml of Gadovist<sup>&#xAE;</sup> 1.0 (Bayer Schering Pharma) 5&#xA0;min prior to DSC perfusion imaging] performed 5&#xA0;months before admission showed rCBV ratios of 1.09 (insular L) and 1.18 (occipital L) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>d). One week before admission, she had woken up with a headache, a paresis of her right arm and an increased speech impairment. In the following days her headache subsided and her paresis was fluctuating. On admission she showed a mixed aphasia, right hemianopia and a complete paresis of her right arm. An electroencephalogram (EEG) showed clear epileptic discharges located left centroparietal without clinical corresponding symptoms. A MRI scan of the brain showed cortical swelling with extensive cortical enhancement of the left temporal lobe (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b), and perfusion-weighted imaging showed rCBV ratios of 2.24 (insular L) and 1.64 (occipital L) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>e), suggesting tumour progression. The patient was treated with anti-epileptic drugs followed by an improvement of clinical symptoms. A repeat MRI made 2&#xA0;months later showed a decrease of enhancement (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c) and of rCBV ratios (1.07 insular L and 0.78 occipital L) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>f) to near-baseline values, indicating the increase in contrast enhancement and rCBV was not due to tumour progression.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>T1-weighted MRI with gadolinium <bold>a</bold> 5&#xA0;months prior to admission, <bold>b</bold> during admission, <bold>c</bold> 2&#xA0;months after admission, <bold>d</bold>&#x2013;<bold>f</bold> DSC perfusion-weighted MRI <bold>d</bold> 5&#xA0;months prior to admission, <bold>e</bold> during admission, and <bold>f</bold> 2&#xA0;months after admission</p></caption><graphic xlink:href="415_2012_6443_Fig1_HTML" id="MO1"/></fig></p>
    <p>Radiological seizure-associated abnormalities in epilepsy have been described before. The changes that can be seen on MR imaging are mainly characterised by focal cortical swelling and diffusion restriction due to cytogenic and vasogenic oedema [<xref ref-type="bibr" rid="CR2">2</xref>], but leptomeningeal and/or cortical enhancement can also be seen [<xref ref-type="bibr" rid="CR3">3</xref>], suggesting a disruption of the blood brain barrier. Recently, Rheims et al. [<xref ref-type="bibr" rid="CR4">4</xref>] described ten patients with extensive transient cortical and leptomeningeal contrast-enhancement in the context of seizures in brain tumour patients previously treated with radiotherapy. They argue that the marked and extensive enhancement they observed (labelled peri-ictal pseudoprogression), might be related to a postradiation vasculopathy. Although they also mention a moderate increase of rCBV in two patients, no data on this are provided, and follow-up rCBV is not mentioned. It is therefore unsure whether their findings were also transient.</p>
    <p>Another late reversible complication seen in brain tumour patients after radiation therapy is the so-called SMART syndrome (stroke-like migraine attacks after radiation therapy) [<xref ref-type="bibr" rid="CR5">5</xref>]. To what extent our case is part of the SMART syndrome and to what extent the SMART syndrome is due to seizures are at present unclear.</p>
    <p>Our case shows that, despite the known association between increased rCBV and tumour progression, rCBV increase should be interpreted with caution, and peri-ictal pseudoprogression should be considered as well.</p>
  </body>
  <back>
    <ack>
      <title>Conflicts of interest</title>
      <p>The authors declare that they have no conflict of interest.</p>
      <sec id="d29e327">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dhermain</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Hau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lanfermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Bent</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas</article-title>
          <source>Lancet Neurol</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>906</fpage>
          <lpage>920</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70181-2</pub-id>
          <pub-id pub-id-type="pmid">20705518</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Briellmann</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Wellard</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Seizure-associated abnormalities in epilepsy: evidence from MR imaging</article-title>
          <source>Epilepsia</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>760</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1528-1167.2005.47604.x</pub-id>
          <pub-id pub-id-type="pmid">15857444</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lansberg</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>O&#x2019;Brien</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Norbash</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Moseley</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Morrell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Albers</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>MRI abnormalities associated with partial status epilepticus</article-title>
          <source>Neurology</source>
          <year>1999</year>
          <volume>52</volume>
          <fpage>1021</fpage>
          <lpage>1027</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.52.5.1021</pub-id>
          <pub-id pub-id-type="pmid">10102423</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rheims</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ricard</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bent</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Peri-ictal pseudoprogression in brain tumour patients</article-title>
          <source>Neuro Oncol</source>
          <year>2011</year>
          <volume>13</volume>
          <fpage>775</fpage>
          <lpage>782</lpage>
          <pub-id pub-id-type="doi">10.1093/neuonc/nor082</pub-id>
          <pub-id pub-id-type="pmid">21727213</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerklaan</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lycklama a Nijeholt</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Wiggenraad</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Berghuis</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Postma</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Taphoorn</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>SMART-syndrome: a late reversible complication after radiation therapy for brain tumours</article-title>
          <source>J Neurol</source>
          <year>2011</year>
          <volume>258</volume>
          <fpage>1098</fpage>
          <lpage>1104</lpage>
          <pub-id pub-id-type="doi">10.1007/s00415-010-5892-x</pub-id>
          <pub-id pub-id-type="pmid">21373901</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
